Nyxoah SA, known for its innovative solutions in treating Obstructive Sleep Apnea, is poised to share significant corporate updates at three upcoming investor conferences in New York City this September.
The presence of CEO Olivier Taelman at these events highlights the company's commitment to transparency and investor engagement, alongside opportunities for one-on-one meetings with institutional investors.
Collection
[
|
...
]